Lori Noffsinger

Biography

Ms. Noffsinger, the VP of Process Development, joined Cognate in 2002. Ms. Noffsinger manages the transition of technologies from research and development through scale up to manufacturing with a focus on clinical and commercial application. Ms. Noffsinger assists in designing and conducting validation and optimization experiments. She also assists in writing and reviewing controlled documents and in technology transfer as well as technical consulting for certain of Cognate’s partners and affiliates. Prior to joining Cognate, Ms. Noffsinger served most recently as an implementation and product specialist for Stemsoft Software Inc., Vancouver, BC. Ms. Noffsinger spent a year traveling to cell processing laboratories, implementing, validating, training and installing laboratory-oriented database software. Ms. Noffsinger is an accomplished Medical Technologist with 14 years of experience in transfusion medicine, beginning with blood bank positions. She also has 7 years of experience in bone marrow cell processing and graft engineering from Johns Hopkins Oncology Center. Ms. Noffsinger worked at Johns Hopkins University from 1996-2001 as a Research and Development Specialist for Oncology/Hematalogic Malignancies. In the Development Immunotherapy Lab, Ms. Noffsinger assisted in effective management of projects and resources to achieve Phase I and Phase II trials for graft engineering, cellular immunotherapy and gene therapy. While at Johns Hopkins (University and Hospital), Ms. Noffsinger collaborated with companies on development of prototypes, verification and validation of several devices, processes, and reagents/drugs. She gained general experience in the areas of immunology, hematopoietic stem cell processing, graft engineering, cell cryopreservation, quality assurance, process validation, regulatory issues, molecular biology, GMP processing and translating research from “bench to clinic.” Her skills include cell selection, elutriation, flow cytometry, designing, performing and validating immunologic assays, writing controlled documents and the training of clinical personnel. She also has experience with ex vivo expansion of bone marrow, cytotoxic T-cells, dendritic cells and other cell types for therapeutic use as well as for clinical research activities for the university and hospital. Ms. Noffsinger earned her B.S. in Medical Technology/Computer Science from Michigan Technological University in Houghton, MI. 

Research Interest

Medical Technology & Computer Science